Skip to main content
Fig. 2 | Health Research Policy and Systems

Fig. 2

From: Intriguing insight into unanswered questions about Mpox: exploring health policy implications and considerations

Fig. 2

Sources: Highlights of prescribing information: JYNNEOS (Smallpox and Monkeypox Vaccine, Live, Nonreplicating), ACAM2000 [Smallpox (Vaccinia) Vaccine, Live]

Informed consent between healthcare workers and individuals for getting the suitable vaccine, either JYNNEOS or ACAM2000, with the warning that the patient must be a patient in the hospital for a reasonable time for clinical surveillance, as there is a risk of developing severe allergic manifestations such as suffocation, swelling, tachycardia or dizziness, which are life-threatening conditions

Back to article page